Patents by Inventor David J. Wiseman

David J. Wiseman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150133546
    Abstract: The lacrimal implant delivery systems and methods described herein provide for controlled release of a therapeutic agent for the treatment of disease, including the treatment of glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agents. Treatment of disease, including glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agent in conjunction with penetration enhancer, such as benzalkonium chloride, and/or artificial tears is also provided.
    Type: Application
    Filed: January 17, 2015
    Publication date: May 14, 2015
    Inventors: Zuhal Butuner, Deepank Utkhede, Sylie Sim, David J. Wiseman
  • Publication number: 20150064230
    Abstract: The lacrimal implant delivery systems and methods described herein provide for controlled release of a therapeutic agent for the treatment of disease, including the treatment of glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agents. Treatment of disease, including glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agent in conjunction with penetration enhancer, such as benzalkonium chloride, and/or artificial tears is also provided.
    Type: Application
    Filed: August 25, 2014
    Publication date: March 5, 2015
    Inventors: Zuhal Butuner, Deepank Utkhede, Sylie Sim, David J. Wiseman
  • Publication number: 20100209477
    Abstract: The lacrimal implant delivery systems and methods described herein provide for controlled release of a therapeutic agent for the treatment of disease, including the treatment of glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agents. Treatment of disease, including glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agent in conjunction with penetration enhancer, such as benzalkonium chloride, and/or artificial tears is also provided.
    Type: Application
    Filed: January 22, 2010
    Publication date: August 19, 2010
    Applicant: QLT PLUG DELIVERY INC.
    Inventors: ZUHAL BUTUNER, Deepank Utkhede, Sylvie Sim, David J. Wiseman